TD Cowen analyst Gary Taylor raised the firm’s price target on HCA Healthcare (HCA) to $490 from $380 and keeps a Buy rating on the shares. The firm said they reported a strong quarter with adjusted EBITDA +11% ahead of consensus and raised FY25 EBITDA Guide by more than $450m at the midpoint.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $494 from $445 at Barclays
- HCA Healthcare price target raised to $525 from $495 at UBS
- HCA Healthcare price target raised to $520 from $470 at Goldman Sachs
- HCA Healthcare price target raised to $425 from $400 at Morgan Stanley
- HCA Healthcare price target raised to $525 from $444 at Cantor Fitzgerald